NSE filing, NSE: REMUS. Summary written from the filing by ALFA Finder's alert engine.
Remus Pharmaceuticals Ltd: key numbers
- Share price
- ₹843.35
- Market cap
- ₹993.8 Cr
- Revenue (annual)
- ₹853.6 Cr
- Net profit (annual)
- ₹36.99 Cr
- P/E (TTM)
- 26.9×Sector 45.9×
- Promoter holding
- 70.95%
- FII holding
- 5.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Remus Pharmaceuticals Ltd
All →Remus Pharmaceuticals Other Announcement
Remus Pharmaceuticals filed its Reg 76 Reconciliation of Share Capital Audit Report for Q1 FY2027. It is a routine depository-compliance certificate with no transaction or business event.
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals Limited shareholders approved the migration of equity shares from the NSE Emerge platform to the main boards of NSE and BSE.
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals held its 11th Annual General Meeting on September 29, 2026. Shareholders discussed financial results, dividend declaration, and director appointments.
Remus Pharmaceuticals Dividend
Remus Pharmaceuticals Limited has fixed September 22, 2026, as the record date for determining shareholder entitlement to a final dividend of Rs. 0.50 per share.
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals Limited has issued a postal ballot notice seeking shareholder approval for the migration of its equity shares from the NSE Emerge platform to Main Board.
Remus Pharmaceuticals Management Change
Remus Pharmaceuticals Limited has appointed Mr. Ashutosh Naginbhai Valani as a Non-Executive Independent Director, effective September 2, 2026.
Other merger & restructuring announcements
All →KS Smart Technologies Merger & Restructuring Worth ₹0.01 Cr
KS Smart Technologies reported completion of a foreign subsidiary's incorporation, KS Smart Global Inc. in USA, on 22 October 2026. Transaction amount is ₹0.01 Crore.
- Value
- ₹0.01 Cr
KS Smart Technologies Merger & Restructuring
KS Smart Technologies reported that its step-down subsidiary KS Smart Global Inc. was incorporated in Delaware, USA, on October 22, 2026. The initial share subscription is stated as up to USD 510, held 51% by KSSPL.
AXISCADES Technologies Merger & Restructuring
AXISCADES Technologies disclosed that its step-down subsidiary Ulosia Holding AG incorporated AKKODIS AXISCADES AEROSPACE CANADA INC. in Canada. No cash was invested by the listed entity, and no value is stated.
Sapphire Foods India Merger & Restructuring
Sapphire Foods received CCI approval under Section 31(1) for its proposed merger into Devyani International under a Scheme of Arrangement. The detailed CCI order is still awaited.
Aditya Ispat Merger & Restructuring
Aditya Ispat's steel slump sale to related party Jai Bapji Ispat now completes by 31 December 2026. Delay stems from pre-closing actions under the business transfer agreement.
Vahh Chemicals Merger & Restructuring Worth ₹0.1 Cr
VAHH Chemicals will incorporate Vedant Nutrition Limited as a wholly owned nutraceutical subsidiary with Rs 0.10 Crore cash. Incorporation is tentatively dated November 5, 2026.
- Value
- ₹0.10 Cr